Skip to main content

New developments in CAR T, CAR NK, and CAR macrophage cell therapies

Edited by:
Zhenshu Xu, MD, PhD, Professor, Fujian Medical University Union Hospital, China

Submission Status: Open   |   Submission Deadline: 2 November 2024


Experimental Hematology & Oncology is calling for submissions to our Collection on 'New developments in CAR T, CAR NK, and CAR macrophage cell therapies.'

About the Collection

Experimental Hematology & Oncology is calling for submissions to our Collection on 'New developments in CAR T, CAR NK, and CAR macrophage cell therapies.' CAR engineered cell therapies are moving rapidly from bench to bedside. This collection welcomes studies covering the latest development in pre-clinical and clinical studies of CAR -engineered cell therapies.

Image credits: © Meletios Verras / Getty Images / iStock

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles and Reviews. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “New developments in CAR T, CAR NK, and CAR macrophage cell therapies" under the “Details” tab during the submission stage. Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editor has no competing interests with the submissions are handled through the peer-review process. The peer-review of any submissions for which the Editor has competing interests is handled by another Editorial Board Member who has no competing interests.